Blog
   
Want to keep informed with the latest from Interactive Media Lab? Simply click here to subscribe to the IML Blog RSS Feed
Apr 29

Written by: IML
Friday, April 29, 2011 12:47 PM  RssIcon

Re-blogged from Bryan M. Wolfe AppAdvice.com April 29th, 2011

While Apple celebrates its continued growth, Research In Motion (RIM) continues seeing its bottom-line erode. Now, The Wall Street Journal is reporting a well-respected analyst is moving its position on the BlackBerry maker from “buy” to “underperform.” This comes at a time when RIM attempts to reboot its business with its new PlayBook tablet.

Once the darling of both Wall Street and Main Street, RIM continues falling behind Apple and Google in the growing smart phone market. In fact, a recent report indicated just 11 percent of future handset buyers would chose a BlackBerry, versus 31 percent for an Android-based device, and 30 percent who indicated they’d buy an iPhone.

Now, weakening sales and uncertainly about the PlayBook are leading to financial downgrades.

According to Jefferies analyst Peter Misek:

We Were Wrong: QNX Too Late and Too Little; Downgrade to Underperform

In addition to lowered May Q guidance, our checks indicate RIMM will see continued execution issues, product delays, and lackluster product launches for the next year. We believe Blackberry OS 7.0 (renamed, formerly 6.1) and QNX will be delayed and that carriers are withdrawing support. We cut our [Fiscal year 2012 (Feb) EPS [estimate] to $5.50 (guidance $7.50), [fiscal year 2013 estimate] to $5 [(versus the street consensus of $7.37)], and [our price] target to $35.

QNX Software Systems is the RIM unit responsible for the PlayBook.

The shares of the Waterloo, Ont.-based company, were off $7.33, or 13.6 per cent, at $46.50 on the Toronto Stock Exchange after touching a low of $46.26 near the start of the session.

The sell-off comes one day after the company said that it shipped fewer BlackBerry smartphones than it expected.


Tags:
Categories:
Location: Blogs Parent Separator The Lab

Your name:
Gravatar Preview
Your email:
(Optional) Email used only to show Gravatar.
Your website:
Title:
Comment:
Add Comment   Cancel